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Abstract
The bicuspid aortic valve (BAV) and specific systemic autoimmune diseases are associated with
cardiovascular manifestation, including aortic aneurysm. We reported a case of 64 year-old patient
with BAV and a history of ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE), and
who developed ascending thoracic aortic aneurysm. The patient presented also the homozygosity
for genetic variants of MMP9, ACE, MTHFR and PAI-1 genes. Gene-environmental interactions may
represent an additional pathogenetic dimension in the still challenging management of the
abnormalities of the aortic wall, including dilatation, aneurysm and dissection.
Introduction
The bicuspid aortic valve (BAV) affects 1 to 2% of the pop-
ulation and may be complicated by abnormalities of the
aortic wall, including dilatation, aneurysm and dissection
[1].
Specific systemic autoimmune diseases are associated
with cardiovascular manifestations, including aortic aneu-
rysm [2,3].
We reported a case of a 64-year-old male with BAV and a
history of ankylosing spondylitis (AS) and systemic lupus
erythematosus (SLE), and who developed ascending tho-
racic aortic aneurysm. In addition we have performed a
genetic screnning of 5 gene polymorphisms (ACE I/D,
MTHFR 677C>T, MMP9-1562C>T, PAI 1 4G/5G; MMP12
A82G) reported in multiple case control studies to be
genetic risk factors for the development of the abdominal
aortic aneurysm (AAA) [4].
Case presentation
The patient was a -64 year-old man, who had a 25-year
history of hypertension and a 8-year history of hypothy-
roidism. In 2000, the patient underwent a corrective oste-
otomy of the spine for ankylosing spondylitis and
spondylarthropathy. He had also been diagnosed as hav-
ing a dilatation of the ascending thoracic aorta associated
to BAV. The patients was treated with metilprednisolone
along with colchicine, and was followed regularly for pro-
gressive aortic dilation.
He was admitted at our hospital for further evaluation on
December 2008. Transthoracic echocardiography
revealed aortic root and ascending aortic dilatation (Fig-
ures 1, 2).
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A computed tomography scan confirmed the presence of
the ascending aorta aneurysm (53 mm) and ectasia of the
aortic root and arch (respectively 45 mm and 42 mm).
The patient was referred to our cardiothoracic surgery
service in order to evaluate the need for aortic root
replacement. Preoperative coronary angiography and aor-
tography confirmed the presence of ascending aortic
aneurysm root without evidence of hemodynamically sig-
nificant stenosis or regurgitation so the cardiac surgeons
decided to postpone surgical treatment at the time when
the valve requires replacement.
Genetic testing was performed by polymerase chain reac-
tion/restriction fragment length polymorphism analysis
in order to identify genotypes patient. The genetic results
for the studied polymorphisms are shown in table 1. The
patient was TT, DD, 5G5G and TT homozygous for the
MMP9-1562C, ACE I/D, PAI 1 4G/5G and MTHFR C677T
genetic polymorphisms, respectively.
Discussion
Patients with AS and SLE may develop cardiovascular
manifestations ranging from asymptomatic forms to life
threatening conditions, including common cardiovascu-
lar manifestation and valvular problems [2,3]. The mech-
anism responsible for the occurrence and progression of
aortic dilatation has also not yet been elucidated in detail.
Aortic aneurysm may be the result of the medial degener-
ation, induced by chronic inflammation and accelerated
by prolonged corticosteroid therapy.
Parasternal short axis view of aortic valve during systole (A)  and diastole (B): BAV with "rafe" (*) between the left coro- nary sinus (LCS) and right coronary sinus (RCS) Figure 1
Parasternal short axis view of aortic valve during sys-
tole (A) and diastole (B): BAV with "rafe" (*) 
between the left coronary sinus (LCS) and right cor-
onary sinus (RCS). NCS: non coronary sinus.
A
B
Parasternal long-axis view showing a dilated aortic root and  ascending aorta Figure 2
Parasternal long-axis view showing a dilated aortic 
root and ascending aorta. Ao: Aorta; Asc Ao: Ascending 
aorta.Cardiovascular Ultrasound 2009, 7:34 http://www.cardiovascularultrasound.com/content/7/1/34
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Aneurism formation may be more common in patients
with the coexistence of BAV. In fact, bicuspid aortic valve
is considered to be a cause of intrinsic changes in the aor-
tic wall resulting in aneurysms of the ascending aorta,
independent of degree of valvular dysfunction [1].
In addition to the presence of BAV and the inflammatory
involvement of the aortic wall by immune diseases and
systemic hypertension, genetic factors may contribute sig-
nificantly to the development of aortic dilation in our
patient. Indeed, our observations are in agreement with
such hypothesis, reporting the presence of homozygosity
for genetic variants of MMP9, ACE, MTHFR and PAI-1
genes that have been previously associated with a signifi-
cant risk of abdominal aortic aneurysm disease [4].
Expression of MMP-9 is elevated in vascular disease, and
in particular within aneurysm tissues. A meta-analysis of
2 larger case-control studies that have looked at the ACE
I/D polymorphism in AAA patients showed a strong over-
all association between ACE D allele (RR 1.33
[1.20e1.48]) and disease [4].
An association between the presence of AAA and elevated
MTHFR 677C>T has been indicated, and meta-analysis of
these studies reveal a significant increased risk of AAA dis-
ease for the T allele variant [4]. Recently, a study suggested
a significant association between growth and plasmino-
gen activator inhibitor (PAI) 1–675 4G/5G and AAA [5].
In the present case report, in addition to inflammatory
involvement of the aortic wall by systemic autoimmune
diseases, these specific genetic variants may have pro-
moted the development of aortic dilation in this patient.
BAV is responsible for a large proportion of patients com-
ing to aortic valve replacement. The mechanism responsi-
ble for the associated vascular complications remains
controversial. Some patients with BAV have rapidly pro-
gressive valve and aortic dysfunction while some remain
without complications.
Several advances in the molecular genetics of aortic valve
disease related to BAV, have recently been made, espe-
cially through the use of linkage analysis. These resulted in
the discovery of mutations in NOTCH1 gene, a signaling
and transcriptional regulator gene on chromosome 9,
NOTCH1 and some different loci linked to BAV on chro-
mosomes 18, 5, and 13 [6].
However, genetic basis of BAV remains unclear. Our data
suggest, for the first time, that some genetic biomarkers
(functional polymorphisms) may predispose BAV
patients at an increased risk of aortic dilatation, aneurysm
formation, and dissection. Our findings are hypothesis
generating and need to be confirmed by further clinical
studies.
Elucidating the genetic basis for BAV may have substantial
implications in clinical practice. Identification of specific
genetic markers may helpful for early clinical detection of
relatives; genetic markers might be also used to predict the
natural progression of the condition and to identify those
cases that might have potentially life-threatening compli-
cations from BAV
Therefore, future studies focusing on the identification of
additional disease-causing and susceptibility genes are
needed in order to improve understanding of the patho-
physiological processes as well as to identify new thera-
peutic strategies.
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Table 1: Genotypes of the studied candidate genes
Gene Polymorphism Biological function Genotypes
MTHFR C677T Reduction in enzyme activity and moderate increase in plasma homocysteine levels TT
MMP9 C1562T ~2-fold higher promoter activity TT
MMP12 A82G Different transcriptional activity (upregulation) AA
ACE I/D I allele is associated with 50% decrease in ACE levels DD
PAI-1 4G/5G The 5G variant is associated with less inhibition of the plasminogen activators and, consequently, 
increased conversion of plasminogen to plasmin and increased activation of MMPs.
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